Today: 20 May 2026
Commonwealth Bank (CBA) share price drops as AUSTRAC eyes suspected $1bn mortgage fraud
27 February 2026
2 mins read

Commonwealth Bank (CBA) share price drops as AUSTRAC eyes suspected $1bn mortgage fraud

Sydney, Feb 27, 2026, 16:55 AEDT — After-hours

  • Commonwealth Bank dropped roughly 1.9% on Friday, despite the broader market finishing at a record high.
  • AUSTRAC is looking into whether money laundering may have involved suspected fraudulent home loans, according to Capital Brief.
  • Investors are eyeing both upcoming bank updates and next week’s GDP release for signs of rate pressure and credit risk.

Shares in Commonwealth Bank of Australia slipped Friday, closing at A$173.87, down 1.9% after Capital Brief reported that AUSTRAC, the country’s financial crimes watchdog, is looking into whether suspected fraudulent home loans at the lender were channeled for money laundering. Still, the stock has risen about 10% this year.

The AUSTRAC piece changes things, pulling the matter out of pure underwriting and into anti-money laundering territory—exactly where regulators can drag their feet and pile on demands. For Australia’s biggest lender, that means even a limited inquiry risks spiraling into drawn-out fixes, audits, and uncomfortable investor scrutiny.

According to Capital Brief, two sources with direct knowledge say AUSTRAC is looking into whether borrowers relied on fake documents to secure loans and purchase property. The report points out that there’s no indication Commonwealth Bank played a role in money laundering. The bank, along with ASIC and AUSTRAC, wouldn’t comment.

Selling pressure hit while the S&P/ASX 200 managed a record finish, climbing 0.25% to end at 9,198.60. That left the bank standing out as one of the few notable laggards among the index’s top stocks heading into the weekend.

Commonwealth Bank flagged roughly A$1 billion worth of home loans to regulators after finding signs they may have been fraudulently secured, Mortgage Professional Australia reported. The bank took a closer look at both its lending paperwork and compliance checks before reporting the suspect loans. According to a spokesperson quoted in the article, attempts to commit fraud are not only persisting but rising in the sector, especially through mortgage brokers and referral partners.

The bank’s message to investors: it’s doubling down on fraud prevention, not loosening up. Chief executive Matt Comyn, in the Feb. 11 half-year statement, positioned the bank’s investment push as an effort to “help combat fraud, scams, cyber threats and financial crime,” with upgrades to tech and lending also in focus. CommBank

Banks aren’t getting any relief from rate jitters. Earlier this week, inflation data surprised to the upside, pushing traders to price in another Reserve Bank of Australia hike before year-end—a move that might boost bank margins, but also turns up the heat on borrowers already feeling the strain.

AUSTRAC, the country’s anti-money laundering agency, steps in—and suddenly lenders face tougher document checks and have to dig deeper into the origins of funds. This tends to mean higher compliance costs and slower approvals on loans long before the impact surfaces elsewhere.

Still, big questions remain. No word yet on the number of loans in play, nor if “fraud” definitely means losses. It’s also not clear if this is limited to a handful of channels and counterparties, which is the line between an ugly headline and something that actually dents earnings.

As Monday’s session kicks off, traders are eyeing any fresh disclosures from Commonwealth Bank. There’s also focus on whether the issue spills over to other major lenders exposed to broker-originated home loans. The calendar’s next major local figure: Australia’s December-quarter GDP, landing March 4 at 11:30am AEDT—just before the RBA’s mid-March policy announcement window.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Vertiv (VRT) stock price dips from record as AI valuation worries bite again
Previous Story

Vertiv (VRT) stock price dips from record as AI valuation worries bite again

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop